A Prospective Clinical Study of Bridging alloHSCT After Treatment With Obinutuzumab in Combination With Chidamide and Venetoclax in RR Ph-ALL and B-cell Lymphoma Patients

Conditions: Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Interventions: Drug: chidamide; Drug: Venetoclax Oral Tablet; Drug: Inotuzumab Ozogamicin Sponsors: Institute of Hematology& Blood Diseases Hospital, China Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials